Vitamin D receptor gene polymorphisms and breast cancer risk among postmenopausal Egyptian women
- PMID: 25804799
- DOI: 10.1007/s13277-015-3332-3
Vitamin D receptor gene polymorphisms and breast cancer risk among postmenopausal Egyptian women
Abstract
Many studies reported that vitamin D can protect against various types of cancers. The mechanism of vitamin D action is mediated by the vitamin D receptor (VDR). VDR may have anti-stress function because it has been identified as p53 direct target gene. This research was designed to investigate the role of VDR polymorphisms BsmI (rs 1544410), ApaI (rs 7975232), TaqI (rs 731236), and FokI (rs 10735810) in pathogenesis of breast cancer using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. The study included 130 postmenopausal breast cancer cases aged 49 to 65 years and 100 controls aged 50 to 72 years. A significantly increased risk of breast cancer among carriers of BsmI bb genotype was observed (OR = 2.5 (1.1-5.6), P = 0.025). Also, a significantly increased risk of breast cancer was detected among women carrying ApaI aa genotype (OR = 2.2 (1.02-4.5), P = 0.04), while no significant associations were observed between breast cancer risk and genotypes and allele frequencies of FokI and TaqI polymorphisms (P > 0.05). Our study showed that VDR gene polymorphisms (BsmI and ApaI) may contribute to breast cancer risk among postmenopausal women.
Similar articles
-
Vitamin D status and vitamin D receptor gene polymorphisms and susceptibility to type 1 diabetes in Egyptian children.Gene. 2014 Feb 25;536(2):430-4. doi: 10.1016/j.gene.2013.12.032. Epub 2013 Dec 23. Gene. 2014. PMID: 24370753
-
Association of vitamin D receptor gene polymorphisms with breast cancer risk in an Egyptian population.Tumour Biol. 2017 Oct;39(10):1010428317727738. doi: 10.1177/1010428317727738. Tumour Biol. 2017. PMID: 29022486
-
Vitamin D receptor gene polymorphisms and prognosis of breast cancer among African-American and Hispanic women.PLoS One. 2013;8(3):e57967. doi: 10.1371/journal.pone.0057967. Epub 2013 Mar 12. PLoS One. 2013. PMID: 23554871 Free PMC article. Clinical Trial.
-
Associations among four polymorphisms (BsmI, FokI, TaqI and ApaI) of vitamin D receptor gene and end-stage renal disease: a meta-analysis.Arch Med Res. 2015 Jan;46(1):1-7. doi: 10.1016/j.arcmed.2014.11.017. Epub 2014 Nov 27. Arch Med Res. 2015. PMID: 25434518 Review.
-
Vitamin D Receptor Polymorphism and Cancer: An Update.Anticancer Res. 2017 Aug;37(8):3991-4003. doi: 10.21873/anticanres.11784. Anticancer Res. 2017. PMID: 28739681 Review.
Cited by
-
Association of Vitamin D Receptor Polymorphisms (FokI (Rs2228570), ApaI (Rs7975232), BsmI (Rs1544410), and TaqI (Rs731236)) with Gastric Cancer in a Kurdish Population from West of Iran.Rep Biochem Mol Biol. 2021 Jan;9(4):435-441. doi: 10.52547/rbmb.9.4.435. Rep Biochem Mol Biol. 2021. PMID: 33969137 Free PMC article.
-
The Impact of Vitamin D and Its Dietary Supplementation in Breast Cancer Prevention: An Integrative Review.Nutrients. 2024 Feb 20;16(5):573. doi: 10.3390/nu16050573. Nutrients. 2024. PMID: 38474702 Free PMC article. Review.
-
A Review of Cancer Genetics and Genomics Studies in Africa.Front Oncol. 2021 Feb 15;10:606400. doi: 10.3389/fonc.2020.606400. eCollection 2020. Front Oncol. 2021. PMID: 33659210 Free PMC article. Review.
-
Role of Hedgehog Signaling in Breast Cancer: Pathogenesis and Therapeutics.Cells. 2019 Apr 25;8(4):375. doi: 10.3390/cells8040375. Cells. 2019. PMID: 31027259 Free PMC article. Review.
-
Vitamin D, Th17 Lymphocytes, and Breast Cancer.Cancers (Basel). 2022 Jul 27;14(15):3649. doi: 10.3390/cancers14153649. Cancers (Basel). 2022. PMID: 35954312 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
